SCCA expression correlates to advanced stage breast carcinomas.

The Stage I, Stage II, and Stage III prognostic TMAs were obtained from CDP. IHC was against SCCA. The tissue was scored and the SCCA-positive cases are shown in parentheses against the number of cases for each stage. Note that all of the normal tissue were SCCA-negative, whereas 14 out of 573 (2.4%) Stage I, 12 out of the 391 (3.1%) Stage II, and 15 out of 174 (8.6%) Stage III cases were SCCA-positive.

本研究中的I期、II期及III期预后组织微阵列（Tissue Microarray, TMA）均取自CDP。采用免疫组化（Immunohistochemistry, IHC）检测鳞状细胞癌抗原（Squamous Cell Carcinoma Antigen, SCCA），并对组织样本进行评分；各分期的SCCA阳性病例数以括号标注于对应总病例数之后。需注意：所有正常组织均呈SCCA阴性；I期573例中有14例（2.4%）、II期391例中有12例（3.1%）、III期174例中有15例（8.6%）的病例为SCCA阳性。